Credo Life Science
Posted on 27th January 2022
Top 10 Pharmaceutical Pellets Companies in World: A Complete Industry Guide
Pharmaceutical pellet manufacturing has grown into a specialized global industry, and understanding what separates leading companies from the rest is essential for any pharma company planning an outsourcing strategy.
What Pellets Are and Why They Matter
Pellets are small, coated multi-particulate units that allow precise control over drug release, taste masking, and dosage flexibility. Their ability to combine multiple release profiles within a single capsule makes them central to modern oral solid dosage design.
Core Evaluation Criteria for Global Leaders
Leading companies are distinguished by WHO-GMP certification, active DMF filings with the USFDA and European regulators, broad technology platforms spanning IR, SR, MR, EC, and ER pellets, and a demonstrated record of successful bioequivalence studies on complex molecules.
The Manufacturing Process Explained
Typical production involves core formation through extrusion-spheronization or layering, precise drying and sizing, functional coating in fluid-bed equipment, rigorous analytical testing, and final filling into capsules, tablets, or sachets — each step directly shaping release performance.
Why Transparency Separates Leaders From the Rest
Companies that share composition, process, and stability data openly with clients enable faster problem-solving and smoother regulatory submissions, while those that withhold this information create friction throughout the development lifecycle.
Evaluating a Manufacturer Before You Commit
A structured evaluation should weigh regulatory credentials, technology breadth, documented bioequivalence success, and scale-up reliability together rather than relying on any single factor. Requesting references from existing clients and independently verifying certifications adds an essential layer of confidence before entering a long-term relationship.
Credo Life Sciences: A Guide in Practice
Credo Life Sciences, a Hyderabad-based company incorporated in 2014, illustrates these principles. It operates WHO-GMP certified facilities with DMF-registered pellets aligned to USFDA, EU, and WHO-GMP requirements, spanning IR, SR, MR, EC, and ER platforms alongside custom taste-masked granules. The company has completed bioequivalence studies on enteric-coated antiplatelet and extended-release antidepressant pellets, and maintains an active R&D pipeline across cardiovascular, metabolic, CNS, and gastrointestinal therapeutic areas.
Conclusion: A complete understanding of pellet technology and regulatory fundamentals is essential groundwork before evaluating any manufacturing partner on the global stage.